Congratulations to Dr. Lingting Shi, a Postdoctoral Research Scientist in the IICD, who was selected as a 2026 STAT Wunderkind. This award recognizes the work of early-career scientists and clinicians.
STAT is a news source affiliated with Boston Globe Media, with a dedicated focus on life sciences, the healthcare industry, and public health policy. Each year, they select up-and-coming scientists from hundreds of nominees, providing complimentary access to their annual STAT Summit, among other community benefits.
At the Institute, Lingting’s research centers on cancer immunology through the lens of single-cell and spatial genomic technologies and computational methods. She is co-mentored by Profs. Elham Azizi and Jose McFaline-Figueroa.
Read the press release: https://www.statnews.com/wunderkinds/
